. Author manuscript; available in PMC: 2017 Feb 10.

Published in final edited form as: J Neuroimmunol. 2008 Jul 3;200(1-2):145–152. doi: 10.1016/j.jneuroim.2008.05.016

Table 1.

Marker allele association with MS and SLE

A. Association with MS

	Gene	5′ to CCL11		3′ to CCL14	Nonsyn CCL14

	Marker	PG13		PG28	PG29
MS–control	χ²	4.34		4.89	4.23
	P	0.037		0.027	0.04
↑Allele		T(T/C)		A(C/A)	T(T/C)
Freq. in controls/MS		0.850/0.882		0.221/0.267	0.936/0.958
B. Association with SLE

	Gene	Nonsyn CCL11	3′ to CCL14	Nonsyn CCL15	5′ to CCL3

	Marker	PG14	PG28	PG38	PG46

SLE–control	χ²	3.96	33.65	5.26	4.01
	P	0.047	6.59⁻⁹	0.022	0.045
↑Allele		G(G/A)	A(C/A)	T(C/T)	G(G/T)
Freq. in controls/SLE		0.818/0.881	0.221/0.460	0.039/0.079	0.633/0.713

All marker alleles with a p<0.05 are indicated for CCL markers in MS (A) and SLE (B). In the row of alleles, the allele that is increased in the disease is indicated and the major and minor alleles of each SNP, respectively, are shown in parenthesis. After Bonferroni correction, only the A (minor) allele of PG28 shows significant association with SLE.